Intravenous Antimicrobial Starts among Hemodialysis Patients in the National Healthcare Safety Network Dialysis Component, 2016-2020

Kidney360. 2023 Jul 1;4(7):971-975. doi: 10.34067/KID.0000000000000167. Epub 2023 May 31.

Abstract

  1. NHSN total IV antimicrobial start rates for patients on hemodialysis decreased from 2016 to 2020, but rates unsupported by NHSN surveillance documentation did not.

  2. There were 80% of reporting hemodialysis facilities that had ≥1 unsupported IV antimicrobial start, and the fraction of facilities with unsupported starts increased yearly.

  3. Accurate reporting and timely review of antimicrobial data is critical to understanding prescribing trends and practices in hemodialysis facilities.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-Infective Agents* / adverse effects
  • Catheter-Related Infections* / epidemiology
  • Catheter-Related Infections* / prevention & control
  • Health Facilities
  • Humans
  • Patients
  • Renal Dialysis / adverse effects

Substances

  • Anti-Infective Agents